Saccharomyces boulardii and Reduced Duration of Diarrhea

• Efficacy and safety of Saccharomyces boulardii CNCM I-745 for the treatment of pediatric acute diarrhea in China: a systematic review and meta-analysis.

  • 2025-06-04
  • Meta-Analysis · n = 1,125
  • Frontiers in cellular and infection microbiology 15
  • • Lynne V McFarland
    • Tong Li

  • PubMed: 40535538
  • DOI: 10.3389/fcimb.2025.1587792

  5 Insights on

  • Reduced Duration of Diarrhea

  • High evidence
  • Clinical

  S. boulardii CNCM I-745 was found to significantly reduce the duration of PAGE (SMD=-1.63 days, 95% CI -2.08, -1.18)

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes

• Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.

  • 2023-10-01
  • Review
  • Cureus 15(10)
  • • Sarath Gopalan
    • Sridhar Ganapathy
    • Monjori Mitra
    • Neha
    • Devesh Kumar Joshi
    • Krishna C Veligandla
    • Rahul Rathod
    • Bhavesh P Kotak

  • PubMed: 37927652
  • DOI: 10.7759/cureus.46314

  3 Insights on

  • Reduced Duration of Diarrhea

  • Low evidence

  Among Indian children with PAGE, S. boulardii CNCM I-745 was found superior to Lactobacillus rhamnosus GG and four strains of Bacillus clausii in shortening the duration of diarrhea and reducing the length of hospital stay.

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes